C. Tefé-Silva, “TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA”, journal, vol. 5, no. 4, pp. 1-6, Apr. 2023.